Cargando…

Targeting structural features of viral genomes with a nano-sized supramolecular drug

RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in protein structure targeting, fail for inherently flexible RNA....

Descripción completa

Detalles Bibliográficos
Autores principales: Melidis, Lazaros, Styles, Iain B., Hannon, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153246/
https://www.ncbi.nlm.nih.gov/pubmed/34123344
http://dx.doi.org/10.1039/d1sc00933h
_version_ 1783698757352685568
author Melidis, Lazaros
Styles, Iain B.
Hannon, Michael J.
author_facet Melidis, Lazaros
Styles, Iain B.
Hannon, Michael J.
author_sort Melidis, Lazaros
collection PubMed
description RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in protein structure targeting, fail for inherently flexible RNA. Herein we harness MD simulations with Markov state modeling to enable nanosize metallo-supramolecular cylinders to explore the dynamic RNA conformational landscape of HIV-1 TAR untranslated region RNA (representative for many viruses) replicating experimental observations. These cylinders are exciting as they have unprecedented nucleic acid binding and are the first supramolecular helicates shown to have anti-viral activity in cellulo: the approach developed in this study provides additional new insight about how such viral UTR structures might be targeted with the cylinder binding into the heart of an RNA-bulge cavity, how that reduces the conformational flexibility of the RNA and molecular details of the insertion mechanism. The approach and understanding developed represents a new roadmap for design of supramolecular drugs to target RNA structural motifs across biology and nucleic acid nanoscience.
format Online
Article
Text
id pubmed-8153246
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-81532462021-06-11 Targeting structural features of viral genomes with a nano-sized supramolecular drug Melidis, Lazaros Styles, Iain B. Hannon, Michael J. Chem Sci Chemistry RNA targeting is an exciting frontier for drug design. Intriguing targets include functional RNA structures in structurally-conserved untranslated regions (UTRs) of many lethal viruses. However, computational docking screens, valuable in protein structure targeting, fail for inherently flexible RNA. Herein we harness MD simulations with Markov state modeling to enable nanosize metallo-supramolecular cylinders to explore the dynamic RNA conformational landscape of HIV-1 TAR untranslated region RNA (representative for many viruses) replicating experimental observations. These cylinders are exciting as they have unprecedented nucleic acid binding and are the first supramolecular helicates shown to have anti-viral activity in cellulo: the approach developed in this study provides additional new insight about how such viral UTR structures might be targeted with the cylinder binding into the heart of an RNA-bulge cavity, how that reduces the conformational flexibility of the RNA and molecular details of the insertion mechanism. The approach and understanding developed represents a new roadmap for design of supramolecular drugs to target RNA structural motifs across biology and nucleic acid nanoscience. The Royal Society of Chemistry 2021-04-05 /pmc/articles/PMC8153246/ /pubmed/34123344 http://dx.doi.org/10.1039/d1sc00933h Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Melidis, Lazaros
Styles, Iain B.
Hannon, Michael J.
Targeting structural features of viral genomes with a nano-sized supramolecular drug
title Targeting structural features of viral genomes with a nano-sized supramolecular drug
title_full Targeting structural features of viral genomes with a nano-sized supramolecular drug
title_fullStr Targeting structural features of viral genomes with a nano-sized supramolecular drug
title_full_unstemmed Targeting structural features of viral genomes with a nano-sized supramolecular drug
title_short Targeting structural features of viral genomes with a nano-sized supramolecular drug
title_sort targeting structural features of viral genomes with a nano-sized supramolecular drug
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153246/
https://www.ncbi.nlm.nih.gov/pubmed/34123344
http://dx.doi.org/10.1039/d1sc00933h
work_keys_str_mv AT melidislazaros targetingstructuralfeaturesofviralgenomeswithananosizedsupramoleculardrug
AT stylesiainb targetingstructuralfeaturesofviralgenomeswithananosizedsupramoleculardrug
AT hannonmichaelj targetingstructuralfeaturesofviralgenomeswithananosizedsupramoleculardrug